Related Experiment Video
Updated: Jun 12, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve
Aurore Keutgens1, Kateryna Shostak, Pierre Close
1Interdisciplinary Cluster for Applied Genoproteomics (GIGA-Research), University of Liege, CHU, Sart-Tilman, Liege, Belgium.
Abstract:
The nuclear and oncogenic BCL-3 protein activates or represses gene transcription when bound to NF-kappaB proteins p50 and p52, yet the molecules that specifically interact with BCL-3 and drive BCL-3-mediated effects on gene expression remain largely uncharacterized. Moreover, GSK3-mediated phosphorylation of BCL-3 triggers its degradation through the proteasome, but the proteins involved in this degradative pathway are poorly characterized. Biochemical purification of interacting partners of BCL-3 led to the identification of CtBP as a molecule required for the ability of BCL-3 to repress gene transcription. CtBP is also required for the oncogenic potential of BCL-3 and for its ability to inhibit UV-mediated cell apoptosis in keratinocytes. We also defined the E3 ligase TBLR1 as a protein involved in BCL-3 degradation through a GSK3-independent pathway. Thus, our data demonstrate that the LSD1/CtBP complex is required for the repressing abilities of an oncogenic I kappaB protein, and they establish a functional link between the E3 ligase TBLR1 and NF-kappaB.
Insights
BCL-3 protein
Area of Science:
- Molecular and Cellular Biology
- Cancer Research
- Gene Regulation
Background:
- The BCL-3 protein's role in gene transcription and oncogenesis is incompletely understood.
- Key interacting partners and degradation pathways of BCL-3 remain largely uncharacterized.
Purpose of the Study:
- To identify novel BCL-3 interacting proteins.
- To elucidate the molecular mechanisms underlying BCL-3's transcriptional repression and oncogenic functions.
- To characterize the pathways involved in BCL-3 degradation.
Main Methods:
- Biochemical purification of BCL-3 interacting partners.
- Functional assays to assess transcriptional activity and oncogenic potential.
- Investigation of protein degradation pathways.
Main Results:
- CtBP was identified as a crucial co-factor for BCL-3-mediated transcriptional repression and oncogenic activity.
- CtBP is essential for BCL-3's ability to inhibit UV-induced apoptosis in keratinocytes.
- The E3 ligase TBLR1 was identified as a component of a GSK3-independent BCL-3 degradation pathway.
Conclusions:
- The LSD1/CtBP complex is essential for the transcriptional repressing function of the oncogenic I kappaB protein, BCL-3.
- A functional link between the E3 ligase TBLR1 and NF-kappaB signaling is established.
- These findings provide new insights into the regulation of BCL-3 and its role in cancer.
Related Concept Videos
Anaphase Promoting Complex
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
